The Swiss government signs a deal to reserve 8,640 doses of Merck & Co.'s antiviral drug molnupiravir beginning in January. (Reuters) COVID-19 drug developmentCOVID-19 pandemic in SwitzerlandCOVID-19 pandemic link embed save